Skip to content

Effectiveness of Jian-Pi-An-Tai formula for the pregnancy outcome of in vitro fertilization and embryo transfer in infertile women: Protocol of a randomized controlled trial

The pregnancy outcome of Jian-Pi-An-Tai formula followed by in vitro fertilization and embryo transfer in infertile women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006742
Enrollment
Unknown
Registered
2022-11-04
Start date
2022-11-14
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertile

Interventions

control group:routine Western medicines
Intervention group:Jianpi-Antai Formula plus routine Western medicines

Sponsors

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medicial University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for infertility and spleen kidney deficiency syndrome; (2) Patients who plan to perform assisted reproductive technology in the Reproductive Department of Run Run Shaw Hospital affiliated to Zhejiang University and plan to perform frozen embryo transfer; the transferred embryos are two superior embryos; (3) 25-40 years old; (4) Patients who have been insured in Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medicial University after embryo transfer; (5) Signed informed consent.

Exclusion criteria

Exclusion criteria: (1)Patients with genital tract malformation or other reproductive system diseases (adenomyosis, endometrial tuberculosis, etc.); (2) Suffering from sexually transmitted diseases or acute inflammation of urogenital system; (3) Patients with serious primary diseases such as cardiovascular, cerebrovascular, kidney, liver and hematopoietic system (4) Patients with serious cognitive impairment and mental illness; (5) Long term exposure to toxic and harmful substances such as radiation or chemicals; (6) Incomplete data or unauthorized use of other treatments; (7) Patients who are allergic to the drugs used in this study.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;Persistent pregnancy rate;Embryo implantation rate;

Secondary

MeasureTime frame
ß-HCG/E2/P;TCM syndrome score;doppler ultrasound;

Countries

China

Contacts

Public ContactQin Zhang
zhqin@zjwh.gov.cn0571-85827891

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026